Dr. Rosen is now pleased to be able to offer a new procedure available to patients with superficial venous insufficiency, the condition leading to the development of symptomatic varicose veins.

Unlike other thermal-based endovenous techniques such as endovenous laser ablation (EVLA) or radiofrequency ablation, Clarivein® does not employ heat to promote closure of treated veins. Rather, Clarivein®, an FDA-approved procedure, employs a process of mechanical occlusion with a chemical assist, or MOCA.

As the acronym MOCA suggests, the technique involves the use of a mechanical device along with sclerotherapy injection of the vein to be treated. Clarivein® infusion catheter system is a specialized catheter with a unique rotating dispersion tip that allows for better, more effective, 360-degree coverage of a sclerosant chemical to treat the incompetent vein. Thermal closure techniques require the use of tumescent local anesthesia: dilute local anesthetic placed around the segment of the vein being treated. Ironically, this is the only part of the procedure that causes discomfort. In contrast, Clarivein® does not require the use of a local anesthetic around the vein. While EVLA is well-tolerated, studies have shown up to 74% less pain experienced by patients who are treated with Clarivein®.

Other benefits to using this new technique aside from minimal discomfort during the procedure include:

• Decreased risk of bruising
• Decreased overall procedure time
• Potentially decreased recovery time

During Dr. Rosen’s initial consultation, he will be able to determine if you are a potential candidate for this exciting new procedure.

Varicose and spider veins are treated by our vein specialist, David I. Rosen, MD. To learn more about varicose and spider vein treatment, please call 847-459-6400 or contact us to make an appointment.